Charles D. Thompson

1.3k citations

39 papers · 877 indexed · h-index 18

Molecular Biology
Cellular and Molecular Neuroscience top 10%
Oncology
Organic Chemistry top 10%
Pharmacology top 5%

Co-authors: Timothy L. Macdonald William Westlin Gerhard Hannig Marion Wittmann George D. Hartman Matthew A. Seager Mark T. Bilodeau Scott D. Kuduk
Topics: Neuroscience and Neuropharmacology Research (11 papers)Receptor Mechanisms and Signaling (11 papers)Peptidase Inhibition and Analysis (7 papers)
Cited by: Cellular and Molecular Neuroscience Pharmacology Toxicology
Journals: Proceedings of the National Academy of Sciences Journal of The Electrochemical Society Clinical Cancer Research
Partner nations: United States India United Kingdom

In The Last Decade

Charles D. Thompson

39 papers receiving 848 citations

Peers

Countries citing papers authored by Charles D. Thompson

Since Specialization

Citations

This map shows the geographic impact of Charles D. Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles D. Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles D. Thompson more than expected).

Fields of papers citing papers by Charles D. Thompson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles D. Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles D. Thompson. The network helps show where Charles D. Thompson may publish in the future.

Co-authorship network of co-authors of Charles D. Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of Charles D. Thompson. A scholar is included among the top collaborators of Charles D. Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles D. Thompson. Charles D. Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical Pharmacokinetics of Ponesimod, a Selective S1P1 Receptor Modulator, in the Treatment of Multiple Sclerosis 2023 ·Clinical Pharmacokinetics ·(unknown),Belén Valenzuela,Charles D. Thompson,Sivi Ouwerkerk‐Mahadevan,Juan José Pérez Ruixo	6
2	Bladder calculi causing irreducible urogenital prolapse 2018 ·BMJ Case Reports ·Charles D. Thompson,(unknown),(unknown)	6
3	Identification of a methoxynaphthalene scaffold as a core replacement in quinolizidinone amide M1 positive allosteric modulators 2014 ·Bioorganic & Medicinal Chemistry Letters ·Scott D. Kuduk,Christina N. Di Marco,(unknown),William J. Ray,Lei Ma,Marion Wittmann,Kenneth A. Koeplinger,Charles D. Thompson,George D. Hartman,Mark T. Bilodeau,Douglas C. Beshore	7
4	Quantitation of Physiological and Biochemical Barriers to siRNA Liver Delivery via Lipid Nanoparticle Platform 2014 ·Molecular Pharmaceutics ·Yan Xu,Mei Ou,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Rena Zhang,Suzie Yeh,Elizabeth Mahan,Yì Wáng,(unknown),Marian E. Gindy,Conrad E. Raab,Charles D. Thompson,Jerome Hochman	30
5	Metabolites of PPI-2458, a Selective, Irreversible Inhibitor of Methionine Aminopeptidase-2: Structure Determination and In Vivo Activity 2013 ·Drug Metabolism and Disposition ·Christopher C. Arico-Muendel,Bruce Belanger,Dennis R. Benjamin,(unknown),(unknown),Jennifer L. DeLorey,(unknown),Ulrike Gradhand,(unknown),Susan E. Hill,Matthew Labenski,Barry A. Morgan,Gary O’Donovan,Kavirayani R. Prasad,Steven R. Skinner,(unknown),Charles D. Thompson,James Wakefield,William Westlin,Kerry White	9
6	Discovery of selective glucocorticoid receptor modulator MK-5932 2011 ·Bioorganic & Medicinal Chemistry ·Christopher J. Bungard,George D. Hartman,(unknown),James J. Perkins,Chang Bai,Philip E. Brandish,(unknown),James C. Hershey,Azriel Schmidt,Yulin Fang,(unknown),Tom Rushmore,Charles D. Thompson,Robert Meißner	16
7	Quinolizidinone carboxylic acid selective M1 allosteric modulators: SAR in the piperidine series 2011 ·Bioorganic & Medicinal Chemistry Letters ·Scott D. Kuduk,Ronald K. Chang,Christina N. Di Marco,William J. Ray,Lei Ma,Marion Wittmann,Matthew A. Seager,Kenneth A. Koeplinger,Charles D. Thompson,George D. Hartman,Mark T. Bilodeau	20
8	N-Heterocyclic derived M1 positive allosteric modulators 2010 ·Bioorganic & Medicinal Chemistry Letters ·Scott D. Kuduk,Christina N. Di Marco,(unknown),(unknown),William J. Ray,Lei Ma,Marion Wittmann,Lone Veng,Matthew A. Seager,(unknown),Charles D. Thompson,George D. Hartman,Mark T. Bilodeau	25
9	Fused heterocyclic M1 positive allosteric modulators 2010 ·Bioorganic & Medicinal Chemistry Letters ·Scott D. Kuduk,Christina N. Di Marco,(unknown),William J. Ray,Lei Ma,Marion Wittmann,Matthew A. Seager,Kenneth A. Koeplinger,Charles D. Thompson,George D. Hartman,Mark T. Bilodeau	14
10	Hydroxy cycloalkyl fused pyridone carboxylic acid M1 positive allosteric modulators 2010 ·Bioorganic & Medicinal Chemistry Letters ·Scott D. Kuduk,Robert M. DiPardo,Douglas C. Beshore,William J. Ray,Lei Ma,Marion Wittmann,Matthew A. Seager,Kenneth A. Koeplinger,Charles D. Thompson,George D. Hartman,Mark T. Bilodeau	15
11	Heterocyclic fused pyridone carboxylic acid M1 positive allosteric modulators 2010 ·Bioorganic & Medicinal Chemistry Letters ·Scott D. Kuduk,Christina N. Di Marco,Ronald K. Chang,William J. Ray,Lei Ma,Marion Wittmann,Matthew A. Seager,Kenneth A. Koeplinger,Charles D. Thompson,George D. Hartman,Mark T. Bilodeau	21
12	Pyridine containing M1 positive allosteric modulators with reduced plasma protein binding 2009 ·Bioorganic & Medicinal Chemistry Letters ·Scott D. Kuduk,Christina N. Di Marco,(unknown),(unknown),William J. Ray,Lei Ma,Marion Wittmann,Matthew A. Seager,(unknown),Charles D. Thompson,(unknown),Mark T. Bilodeau	20
13	An inhibitor of methionine aminopeptidase type-2, PPI-2458, ameliorates the pathophysiological disease processes of rheumatoid arthritis 2008 ·Inflammation Research ·Douglas Lazarus,(unknown),(unknown),(unknown),Matthew Labenski,James Wakefield,Russell Karp,(unknown),(unknown),Jennifer Hoyt,Charles D. Thompson,Gerhard Hannig,William Westlin	11
14	Methionine aminopeptidases type I and type II are essential to control cell proliferation 2005 ·Journal of Cellular Biochemistry ·Sylvie G. Bernier,(unknown),Charles D. Thompson,William Westlin,Gerhard Hannig	59
15	A methionine aminopeptidase-2 inhibitor, PPI-2458, for the treatment of rheumatoid arthritis 2004 ·Proceedings of the National Academy of Sciences ·Sylvie G. Bernier,Douglas Lazarus,(unknown),(unknown),Matthew Labenski,Charles D. Thompson,William Westlin,Gerhard Hannig	84
16	Mechanisms of idiosyncratic drug reactions: the case of felbamate 2002 ·Chemico-Biological Interactions ·Christine M. Dieckhaus,Charles D. Thompson,Shane Roller,Timothy L. Macdonald	57
17	The Synthesis, In Vitro Reactivity, and Evidence for Formation in Humans of 5-Phenyl-1,3-oxazinane-2,4-dione, a Metabolite of Felbamate 2000 ·Drug Metabolism and Disposition ·Charles D. Thompson,Thomas A. Miller,(unknown),Christine M. Dieckhaus,R. Duane Sofia,Timothy L. Macdonald	14
18	The synthesis and evaluation of temperature sensitive tubulin toxins 1999 ·Bioorganic & Medicinal Chemistry Letters ·Thomas A. Miller,(unknown),Charles D. Thompson,Timothy L. Macdonald	1
19	The synthesis and evaluation of benzannelated-azatoxins: The benzazatoxins 1998 ·Bioorganic & Medicinal Chemistry Letters ·Thomas A. Miller,(unknown),Marc Labroli,Charles D. Thompson,(unknown),Timothy L. Macdonald	10
20	Mechanisms of Adrenergic Agonist Induced Allergy Bioactivation and Antigen Formation 1997 ·Experimental Eye Research ·Charles D. Thompson,Timothy L. Macdonald,Michael E. Garst,(unknown),Stephen A. Munk	18

About Charles D. Thompson

Charles D. Thompson is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Oncology, having authored 39 papers that have together received 877 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (11 papers), Receptor Mechanisms and Signaling (11 papers) and Peptidase Inhibition and Analysis (7 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (268 citations), Pharmacology (109 citations) and Toxicology (36 citations). Charles D. Thompson has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include Timothy L. Macdonald, William Westlin, Gerhard Hannig, Marion Wittmann, George D. Hartman, Matthew A. Seager, Mark T. Bilodeau, Scott D. Kuduk, Sylvie G. Bernier and William J. Ray. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of The Electrochemical Society and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact